NIH | National Cancer Institute | NCI Wiki  

Error rendering macro 'rw-search'

null

Versions Compared

Old Version 4

changes.mady.by.user Santana, Luis (NIH/NCI) [C]

Saved on

compared with

New Version 5

changes.mady.by.user Santana, Luis (NIH/NCI) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

General Questions

                                                                                                                                                                                                                                                                                                  

...

  • Crossover is for disease-based cohorts and going from cohort 1 to cohort 2 is for drug exposure-based cohorts. The latter requires reassignment. For crossover, once they have enrolled to the first step and gotten their treatment assignment and patient progresses, they are eligible for a crossover.
  • They would:
    • Enroll to step 2 on the treatment protocol
    • Assign a crossover treatment

ComboMATCH Questions

Our studies have a planned follow up after the treatment completion and PMI Off Treatment forms. These will be used to roll out follow up folders in Rave. Will NRG receive information that a patient is assigned to a different ComboMATCH protocol, and will we receive notification our follow up should be stopped?

...